Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dialysis
Pharma
Akebia drops Vafseo trial, failing to get 'alignment' with FDA
Akebia has scrapped plans for a trial that would have potentially led to an expansion of the patient population for its new anemia drug Vafseo.
Kevin Dunleavy
Oct 29, 2025 11:31am
Baxter offers recovery timeline at storm-hit IV fluid facility
Oct 9, 2024 3:37pm
DaVita doubts broad benefit of Novo's Ozempic in kidney disease
Oct 12, 2023 3:32pm
AZ targets people who don't know they have CKD in new spot
Jan 27, 2023 7:30am
After pair of losses, Ardelyx's CKD prospect finds FDA foothold
Nov 17, 2022 8:05am
FDA flags concerns about Ardelyx's kidney disease prospect
Nov 15, 2022 10:48am
